Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience

Background/aim: To investigate the similarities and differences of renal clinical and renal pathology between IgA nephropathy (IgAN) and IgA vasculitis nephritis (IgAVN) in children. Materials and methods: A total of 237 children with IgAN and 190 children with IgAVN were included. The general conditions, clinical characteristics, final diagnosis, clinical and pathological classification of the children were intercepted at the time of admission, and the retrospective comparative analysis was carried out. Results: The results showed that the median course of disease in IgAN group was longer than that in IgAVN group (p = 0.02). Patients with IgAN had a significantly higher duration of infection than the patients with IgAVN (p = 0.03). The white blood cell count (WBC), hemoglobin (HGB) in IgAN group were significantly lower than that in IgAVN group (p = 0.02). The serum creatinine in IgAN group was higher than that in IgAVN group (p = 0.02). Patients with IgAN and IgAVN had statistically significant differences in pathological typing between clinical types: hematuria and proteinuria, nephrotic syndrome and chronic nephritis (p = 0.004). Conclusion: The clinical manifestations of IgAN and IgAVN were similar, but the onset of IgAN was hidden and the clinical manifestations were relatively serious. Renal pathology was mainly glomerulosclerosis and renal tubular atrophy. IgAVN was characterized by acute onset and good renal function. Renal pathology was dominated by endothelial hyperplasia and crescent formation. These differences did not support the hypothesis that the two diseases are the same.Key words: IgA nephropathy, IgA vasculitis nephritis, children, clinical and pathological features of kidney, anaphylactoid purpura

PDF

___

1. Pohl M. Henoch-Schonlein purpura nephritis. Pediatric Nephrology 2015; 30 (2): 245-252. doi: 10.1007/s00467-014-2815- 6
2. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Archives of Disease in Childhood 2005; 90 (9): 916-920. doi: 10.1136/ adc.2005.074641
3. Jennette JC, Falk RJ, Alba MA. Nomenclature of Vasculitides: 2012 Revised International Chapel Hill Consensus Conference. Systemic Vasculitides: Current Status and Perspectives; 2016. pp. 15-28.
4. Novak J, Moldoveanu Z, Renfrow MB, Suzuki H, Suzuki H et al. IgA Nephropathy and Henoch-Schoenlein Purpura Nephritis: Aberrant Glycosylation of IgA1, Formation of IgA1- Containing Immune Complexes, and Activation of Mesangial Cells. Contributions to Nephrology 2007; 157: 134-138. doi: 10.1159/000102455
5. Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association. Evidence based guidelines for diagnosis and treatment of primary IgA nephropathy (2016). Zhonghua Er Ke Za Zhi 2017; 55 (9): 643-646. doi: 10.3760/cma.j. issn.0578-1310.2017.09.002
6. Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association. Evidence based guidelines for the diagnosis and treatment of Henoch Schonlein purpura nephritis (2016). Zhonghua Er Ke Za Zhi 2017; 55 (9): 647-651. doi:10.3760/j.issn:0578-1310.2007.04.009
7. Meadow SR, Scott DG. Berger disease: Henoch-Schönlein syndrome without the rash. Journal of Pediatrics 1985; 106 (1): 1-11. doi: 10.1016/s0022-3476(85)80459-5
8. Evans DJ, Williams DG, Peters DK, Sissons JG, Boulton-Jones JM et al. Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. BMJ-British Medical Journal 1973; 3 (5875): 326-328. doi: 10.1136/bmj.3.5875.326
9. Lee SMK, Rao VM, Franklin WA, Schiffer MS, Aronson AJ et al. IgA nephropathy: Morphologic predictors of progressive renal disease. Human Pathlogy 1982; 13(4): 314-322. doi: 10.1016/ s0046-8177(82)80221-9.
10. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR et al. Prognosis of Henoch-Schonlein nephritis in children. BMJ-British Medical Journal 1977; 2 (6078): 11-14. doi: 10.1136/ bmj.2.6078.11
11. Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. kidney international 2017; 91 (5): 1014-2021. doi: 10.1016/j.kint.2017.02.003
12. Barbour SJ, Reich HN. Risk Stratification of Patients With IgA Nephropathy. American Journal of Kidney Diseases 2012; 59 (6): 865-873. doi: 10.1053/j.ajkd.2012.02.326
13. Assadi F. Childhood Henoch-Schonlein Nephritis A Multivariate Analysis of Clinical Features and Renal Morphology at Disease Onset. Iranian Journal of Kidney Diseases 2009; 3 (1): 17-21.
14. Pohl M. Henoch-Schönlein purpura nephritis. Pediatric Nephrology 2015; 30 (2): 245-252. doi: 10.1007/s00467-014- 2815-6
15. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Seminars in Nephrology 2004; 24 (3): 197-217. doi: 10.1016/j.semnephrol.2004.01.002
16. Pillebout E. IgA Vasculitis and IgA Nephropathy: Same Disease? Journal of Clinical Medicine 2021; 10 (11): 2310. doi: 10.3390/jcm10112310
17. Working Group for National Survey on Statu sof Dia. A multicenter retrospective study on the diagnosis and treatment of Henoch Schonlein purpura nephritis in children. Chinese Journal of Pediatrics 2013; 51 (12): 881-887. doi:10.3760/cma.j .issn.0578-1310.2013.12.001.
18. Zhang YL, Yu XY, Wang WT, Li Y, Feng XL. Comparative analysis of clinical characteristics between IgA nephropathy and Henoch-Schonlein purpura nephritis. Journal of Shanxi Medical University 2017; 48 (01): 54-58. doi:10.13753/j. issn.1007-6611.2017.01.012
19. Xie M, Feng SP, Luo W, Wang L, Duan QW et al. Clinical and pathological analysis of 258 children with primary IgA nephropathy. Journal of clinical nephrology 2019; 19 (8): 563- 566. doi:10.3969/j.issn.1671-2390.2019.08.003
20. Su CH, Liu ZS, Liu D. Analysis of Clinical and Pathological Features in 97 Children with IgA Nephropathy. Journal of Applied Clinical Pediatrics 2012; 27 (5): 389-390. doi:10./396/j. issn.1003-515X.2012.07.029
21. Zhou CH, Cai LX, Zhu YW, Ju JX, Xu H. A comparison study on clinical and pathological changes between IgA nephropathy (IgAN) and IgA vasculitis nephritis (IgAVN). Zhejiang clinical medicine 2007; 009 (004): 437-438. doi:10.3969/j.issn.1008- 7664.2007.04.003
22. Ye SW, Fang MJ, He WX, Zhu GH. Comparative analysis of IgA nephropathy and Henoch Schonlein purpura nephritis. Journal of Clinical Pediatrics 2003; 18 (11): 904-905. doi:CNKI:SUN:SYQK.0.2003-11-027
23. Koji I, Baseer KA, Asaka H, Takaya O, Masahiko A et al. Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Sch?nlein purpura nephritis: a multicenter retrospective cohort study. BMC Nephrology 2018; 19 (1): 208-217. doi:10.1186/s12882- 018-1009-z
24. Yu L, Liu L, Zhao GC. Clinical and pathological analysis of 55 cases of Henoch Schonlein purpura nephritis in children. Journal of clinical pediatrics 2010; 28 (7): 670-674. doi:10.3969/j.issn.1000-3606.2010.07.020